文献速递焦虑、强迫与应激相关障碍儿童青少年精神

深度学习算法在唐氏综合征儿童大型队列中揭示焦虑障碍的基因组标记

Deep learning algorithms reveal genomic markers for anxiety disorder in a large cohort of children with down syndrome.
PubMed 文献 · Mol Psychiatry · 2025-05-24

本研究利用1479名唐氏综合征个体及家属的全基因组测序队列,其中255名先证者确诊至少一种精神障碍、74名确诊焦虑障碍,采用神经网络深度学习模型分析基因组变异。发现仅19%的焦虑特异性基因变异与唐氏综合征焦虑共享变异重叠,提示唐氏综合征焦虑具有独特分子机制,并识别出29个含反复焦虑特异性变异的生物标志物。

要点

  • 唐氏综合征焦虑障碍的基因变异仅19%与既往报道的焦虑特异性变异重叠。
  • 非编码变异尤其是剪接位点附近的变异在唐氏综合征焦虑中起重要作用。
  • 识别出29个含反复焦虑特异性变异的生物标志物,辅助唐氏综合征人群焦虑诊断。

核心结论

  • 唐氏综合征患者的焦虑障碍具有区别于其他精神障碍的独特分子模式。

研究设计与样本

  • 采用神经网络深度学习模型,分析1479名唐氏综合征个体及家属的全基因组测序队列,其中255名先证者确诊至少一种精神障碍,74名确诊焦虑障碍。

主要发现

  • 仅19%的焦虑特异性对应基因变异与唐氏综合征焦虑共享变异重叠。
  • 功能过度代表分析提示焦虑由遗传与环境因素复杂交互所致。
  • 非编码变异尤其是剪接位点附近的变异起重要作用。
  • 与焦虑及其他精神障碍相关的变异在全基因组分布并非独特。
  • 17q25、16q23、21q22和22q13等位点在唐氏综合征患者中权重更大。

关键数值与推荐

  • 仅19%的焦虑特异性对应基因变异与唐氏综合征焦虑共享变异重叠。
  • 识别出29个含反复焦虑特异性变异的生物标志物。
  • 17q25、16q23、21q22和22q13等位点在唐氏综合征患者中显示更大权重。

临床怎么用

  • 研究提示唐氏综合征焦虑的分子机制独特,可考虑将29个生物标志物用于辅助诊断。
  • 非编码及剪接位点附近变异的重要性提示分析基因组时应关注非编码区域。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite a significant burden of neurobehavioral and psychiatric comorbidities in children with Down syndrome (DS), and the general increased risk for anxiety in individuals with intellectual disabilities (ID), children with DS have significantly lower odds of anxiety. Understanding the specific mechanisms of anxiety in DS could inform the development of new treatments. This study performed a comprehensive investigation of genomic variants that contribute to anxiety disorders in DS, as well as variants shared in other mental disorders. We employed deep learning algorithms using neural network models in combination with one of the largest whole-genome sequencing (WGS) cohorts of 1479 DS individuals and family members, including 255 DS probands diagnosed with at least one type of mental disorder, of whom 74 had confirmed anxiety disorders. We found that only a fraction (19%) of anxiety-specific corresponding gene variants previously reported overlap with those shared in anxiety in DS patients, suggesting distinct molecular mechanisms for anxiety in DS individuals. Functional overrepresentation analysis suggested that anxiety results from a complex interplay of genetic and environmental factors. Additionally, non-coding variants, particularly those proximal to splicing sites, play significant roles. Moreover, the variants associated with anxiety and other mental disorders are not uniquely distributed genome wide. Several loci, including 17q25, 16q23, 21q22, and 22q13, show greater weight in DS patients. Furthermore, 29 biomarkers containing recurrent anxiety-specific variants were identified to assist in the diagnosis of anxiety in the DS population. This pioneering study represents the first comprehensive exploration of anxiety disorders in DS utilizing WGS cohorts and advanced deep-learning AI models. The results indicate that anxiety disorder in DS patients has distinct molecular patterns from other mental disorders. The insights gained from our research offer valuable understanding of underlying mechanisms and hold promise for enhancing clinical diagnosis and potentially guiding more effective intervention strategies in this vulnerable population.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liu Y, Qu HQ, Chang X, et al. Deep learning algorithms reveal genomic markers for anxiety disorder in a large cohort of children with down syndrome. Mol Psychiatry. 2025. PMID: 40413309. doi:10.1038/s41380-025-03065-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。